Results 111 to 120 of about 170,520 (332)

Autosomal Dominant Retinal Dystrophies Caused by a Founder Splice Site Mutation, c.828+3A>T, in PRPH2 and Protein Haplotypes in trans as Modifiers. [PDF]

open access: yes, 2016
PurposeWe determined the phenotypic variation, disease progression, and potential modifiers of autosomal dominant retinal dystrophies caused by a splice site founder mutation, c.828+3A>T, in the PRPH2 gene.MethodsA total of 62 individuals (19 families)
Birch, David G   +7 more
core  

Global Insights from Patients, Providers, and Staff on Challenges and Solutions in Managing Neovascular Age-Related Macular Degeneration

open access: yesOphthalmology and Therapy
Introduction Neovascular age-related macular degeneration is a global public-health concern, associated with a considerable burden to individuals, healthcare systems, and society.
Anat Loewenstein   +22 more
doaj   +1 more source

The gut–eye axis: from brain neurodegenerative diseases to age-related macular degeneration

open access: yesNeural Regeneration Research
Age-related macular degeneration is a serious neurodegenerative disease of the retina that significantly impacts vision. Unfortunately, the specific pathogenesis remains unclear, and effective early treatment options are consequently lacking.
Qianzi Jin   +4 more
doaj   +1 more source

Drug Delivery Technologies for the Treatment of Age-Related Macular Degeneration. [PDF]

open access: yesAdv Sci (Weinh)
There are multiple therapeutic agents available for the treatment of both dry age‐related macular degeneration (AMD) and wet AMD. It is essential to continue innovation by introducing new drug delivery technologies that can incorporate those along with patient compliance and the accessibility of the technology into the early stages of research and ...
Rodriguez-Cruz JJ   +4 more
europepmc   +2 more sources

Integrated Roles of Systemic Diseases and Serum Biomarkers in the Incidence of Age‐Related Macular Degeneration: The UK Biobank Study

open access: yesMedicine Bulletin, EarlyView.
ABSTRACT Background To evaluate the associations of systemic diseases with AMD incidence and explore whether polygenic risk score (PRS) for AMD influences these associations. To assess the impacts of polymorbidities and serum biomarkers on AMD risk. Methods This prospective study of 471156 AMD‐free UK Biobank participants assessed systemic diseases ...
Jun Yu   +9 more
wiley   +1 more source

Abnormal Serum Lipid Levels and Ocular Metabolic Mediators in Adult‐Onset Myopia: A Cohort Study

open access: yesMedicine Advances, EarlyView.
Elevated levels of “good cholesterol” markers apolipoprotein A (APOA) and high‐density lipoprotein cholesterol (HDL‐C) were prospectively associated with an increased risk of developing adult‐onset myopia, whereas higher levels of “bad cholesterol” markers apolipoprotein B (APOB) and low‐density lipoprotein cholesterol (LDL‐C) were associated with a ...
Feipeng Jiang   +9 more
wiley   +1 more source

Fine‐Tuning Photochemical Immunogenic Cell Death by a Panel of Verteporfin‐Lipid Nanoparticles: A Data‐Driven Approach

open access: yesSmall Science, EarlyView.
The relationship between the attributes of verteporfin‐lipid nanoparticles and the exposure of immunogenic cell death markers (HSP‐70, HMGB1, and calreticulin) following 690 nm light activation in murine pancreatic cancer cells. Immunogenic cell death (ICD) is an immunostimulatory process that can be induced by light‐activated photosensitizers, but its
Nimit Shah   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy